274 related articles for article (PubMed ID: 27861759)
1. Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER-Medicare data.
Drahos J; Ricker W; Pfeiffer RM; Cook MB
Cancer; 2017 Feb; 123(4):657-665. PubMed ID: 27861759
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.
Drahos J; Li L; Jick SS; Cook MB
Cancer Epidemiol; 2016 Jun; 42():9-14. PubMed ID: 26972225
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data.
Drahos J; Ricker W; Parsons R; Pfeiffer RM; Warren JL; Cook MB
J Clin Gastroenterol; 2015 Apr; 49(4):282-8. PubMed ID: 24671095
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.
Shaheen N; Ransohoff DF
JAMA; 2002 Apr; 287(15):1972-81. PubMed ID: 11960540
[TBL] [Abstract][Full Text] [Related]
5. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.
Veugelers PJ; Porter GA; Guernsey DL; Casson AG
Dis Esophagus; 2006; 19(5):321-8. PubMed ID: 16984526
[TBL] [Abstract][Full Text] [Related]
6. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
Wang Z; Shaheen NJ; Whiteman DC; Anderson LA; Vaughan TL; Corley DA; El-Serag HB; Rubenstein JH; Thrift AP
Am J Gastroenterol; 2018 Aug; 113(8):1148-1155. PubMed ID: 29880962
[TBL] [Abstract][Full Text] [Related]
8. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population.
Bakr O; Zhao W; Corley D
J Clin Gastroenterol; 2018; 52(10):873-879. PubMed ID: 29356784
[TBL] [Abstract][Full Text] [Related]
11. The Influence of Antireflux Surgery on Esophageal Cancer Risk in England: National Population-based Cohort Study.
Markar SR; Arhi C; Leusink A; Vidal-Diez A; Karthikesalingam A; Darzi A; Lagergren J; Hanna GB
Ann Surg; 2018 Nov; 268(5):861-867. PubMed ID: 30048317
[TBL] [Abstract][Full Text] [Related]
12. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
13. Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium.
Drahos J; Xiao Q; Risch HA; Freedman ND; Abnet CC; Anderson LA; Bernstein L; Brown L; Chow WH; Gammon MD; Kamangar F; Liao LM; Murray LJ; Ward MH; Ye W; Wu AH; Vaughan TL; Whiteman DC; Cook MB
Int J Cancer; 2016 Jan; 138(1):55-64. PubMed ID: 26175109
[TBL] [Abstract][Full Text] [Related]
14. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis.
Inadomi JM; Sampliner R; Lagergren J; Lieberman D; Fendrick AM; Vakil N
Ann Intern Med; 2003 Feb; 138(3):176-86. PubMed ID: 12558356
[TBL] [Abstract][Full Text] [Related]
15. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
Duggan C; Onstad L; Hardikar S; Blount PL; Reid BJ; Vaughan TL
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):934-43. PubMed ID: 23466711
[TBL] [Abstract][Full Text] [Related]
16. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
Schneider JL; Corley DA
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):353-364. PubMed ID: 28577761
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
Runge TM; Abrams JA; Shaheen NJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
[TBL] [Abstract][Full Text] [Related]
18. Adiposity and columnar-lined esophagus.
Lenglinger J; Eisler M; Riegler FM
Am J Gastroenterol; 2008 May; 103(5):1316-7. PubMed ID: 18477363
[No Abstract] [Full Text] [Related]
19. Cigarette smoking and the risk of Barrett's esophagus.
Kubo A; Levin TR; Block G; Rumore G; Quesenberry CP; Buffler P; Corley DA
Cancer Causes Control; 2009 Apr; 20(3):303-11. PubMed ID: 18853262
[TBL] [Abstract][Full Text] [Related]
20. Barrett's Esophagus and Esophageal Adenocarcinoma: How Common Are They Really?
Thrift AP
Dig Dis Sci; 2018 Aug; 63(8):1988-1996. PubMed ID: 29671158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
